{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:18:35Z","timestamp":1767212315824,"version":"3.40.5"},"reference-count":53,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>There exists a paucity of data on pharmacoepidemiologic and drug utilization\npatterns of non-steroidal anti-inflammatory drugs (NSAIDs) in the Middle East region.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The objective of this study was to provide a critical appraisal of the prescription patterns\nof NSAIDs in the Middle East region.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A literature search was conducted on the electronic databases such as MEDLINE,\nGoogle Scholar, and ScienceDirect for studies conducted on prescription pattern of NSAIDs using\nthe keywords \u201cNon-steroidal Anti-inflammatory Drugs\u201d, \u201cNSAIDs\u201d, \u201cNon-opioid Analgesics\u201d,\n\u201cAntipyretics\u201d, \u201cPrescription Pattern\u201d, \u201cDrug Use indicators\u201d, \u201cDrug Utilization Pattern\u201d,\n\u201cPharmacoepidemiology\u201d. The search was conducted within 5 months, from January to May\n2021.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Studies from twelve Middle Eastern countries were analyzed and critically discussed. The\nfindings indicated widespread and clinically significant inappropriate prescribing in all Middle\nEast countries and territories. Furthermore, NSAIDs prescription pattern in the region extensively\nvaries with healthcare settings, patient\u2019s age, patient\u2019s medical presentation, history of comorbid\nconditions, insurance type, and prescribers\u2019 specialization and years of experience, among several\nother factors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Low-quality prescribing based on indicators of the World Health Organization\/\nInternational Network of Rational Use of Drugs suggests the need to further improve the current\ndrug utilization trend in the region.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886318666230220140810","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T10:56:54Z","timestamp":1676890614000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prescribing Pattern of Non-steroidal Anti-inflammatory Drugs (NSAIDs)\nin the Middle East Region: A Critical Review"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5062-0721","authenticated-orcid":true,"given":"Omar Yahya","family":"Al-Shargi","sequence":"first","affiliation":[{"name":"College of Pharmacy, Riyadh Elm University, Riyadh, 11681, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"35","author":"Turman M.","year":"2010","unstructured":"Turman M.; Marnett E.; Prostaglandin endoperoxide synthases. In: Comprehensive Natural Products II. Elsevier: Amsterdam, 2010,35-63"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"Ricciotti E.","year":"2011","unstructured":"Ricciotti E.; FitzGerald G.A.; Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 2011,31(5),986-1000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0165-6147(96)01017-6","volume":"18","author":"Fr\u00f6lich J.C.","year":"1997","unstructured":"Fr\u00f6lich J.C.; A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol Sci 1997,18(1),30-34","journal-title":"Trends Pharmacol Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1007\/s10620-005-2802-7","volume":"50","author":"Gudis K.","year":"2005","unstructured":"Gudis K.; Sakamoto C.; The role of cyclooxygenase in gastric mucosal protection. Dig Dis Sci 2005,50(Suppl. 1),S16-S23","journal-title":"Dig Dis Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2165\/11209470-000000000-00000","volume":"72","author":"Scott L.J.","year":"2012","unstructured":"Scott L.J.; Intravenous Ibuprofen. Drugs 2012,72(8),1099-1109","journal-title":"Drugs"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-4939-6976-0_21","author":"Tolba R.","year":"2017","unstructured":"Tolba R.; Nonsteroidal anti-inflammatory drugs (NSAIDs). Treatment of Chronic Pain Conditions: A Comprehensive Handbook 2017,77-79","journal-title":"Treatment of Chronic Pain Conditions: A Comprehensive Handbook"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.therap.2018.11.002","volume":"74","author":"Moore N.","year":"2019","unstructured":"Moore N.; Duong M.; Gulmez S.E.; Blin P.; Droz C.; Pharmacoepidemiology of non-steroidal anti-inflammatory drugs. Therapie 2019,74(2),271-277","journal-title":"Therapie"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/B978-0-7020-4084-9.00057-4","author":"Lee M.C.","year":"2012","unstructured":"Lee M.C.; Abrahams M.; Pain and analgesics. In: Clinical Pharmacology. 11th ed. Elsevier Inc: Amsterdam, 2012,278-294"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/B978-0-7234-3691-1.00066-0","author":"Cron R.Q.","year":"2013","unstructured":"Cron R.Q.; Weiser P.; Beukelman T.; Juvenile idiopathic arthritis. Clinical Immunology: Principles and Practice 2013,637-47","journal-title":"Clinical Immunology: Principles and Practice"},{"key":"ref=10","first-page":"CD001751","author":"Marjoribanks J.","year":"2003","unstructured":"Marjoribanks J.; Proctor M.L.; Farquhar C.; Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst Rev 2003(4),CD001751","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001751.pub2","author":"Marjoribanks J.","year":"2010","unstructured":"Marjoribanks J.; Proctor M.; Farquhar C.; Nonsteroidal antiinflammatory drugs for dysmenorrhoea. In: Cochrane Database of Systematic Reviews. John Wiley and Sons, Ltd.: New York, 2010"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0002-9343(01)00834-8","volume":"111","author":"Aronoff D.M.","year":"2001","unstructured":"Aronoff D.M.; Neilson E.G.; Antipyretics: Mechanisms of action and clinical use in fever suppression. Am J Med 2001,111(4),304-315","journal-title":"Am J Med"},{"key":"ref=13","first-page":"869","author":"Lee J.J.","year":"2018","unstructured":"Lee J.J.; Simmons D.L.; Antipyretic therapy: Clinical pharmacology. In: Handbook of clinical neurology. Elsevier: Amsterdam 2018,869-881"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40272-016-0165-5","volume":"18","author":"Sivanandan S.","year":"2016","unstructured":"Sivanandan S.; Agarwal R.; Pharmacological closure of patent ductus arteriosus: Selecting the agent and route of administration. Paediatr Drugs 2016,18(2),123-138","journal-title":"Paediatr Drugs"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.2174\/0929867321666140304095434","volume":"21","author":"Irmesi R.","year":"2014","unstructured":"Irmesi R.; Marcialis M.A.; Anker J.V.D.; Fanos V.; Non-steroidal anti-inflammatory drugs (NSAIDs) in the management of patent ductus arteriosus (PDA) in preterm infants and variations in attitude in clinical practice: A flight around the world. Curr Med Chem 2014,21(27),3132-3152","journal-title":"Curr Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2165\/00002018-200225040-00002","volume":"25","author":"Gaynes B.I.","year":"2002","unstructured":"Gaynes B.I.; Fiscella R.; Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: A safety review. Drug Saf 2002,25(4),233-250","journal-title":"Drug Saf"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.survophthal.2009.07.005","volume":"55","author":"Kim S.J.","year":"2010","unstructured":"Kim S.J.; Flach A.J.; Jampol L.M.; Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol 2010,55(2),108-133","journal-title":"Surv Ophthalmol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00055735-199808000-00007","volume":"9","author":"Nichols J.","year":"1998","unstructured":"Nichols J.; Snyder R.W.; Topical nonsteroidal anti-inflammatory agents in ophthalmology. Curr Opin Ophthalmol 1998,9(4),40-44","journal-title":"Curr Opin Ophthalmol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"Zhao X.","year":"2017","unstructured":"Zhao X.; Xu Z.; Li H.; NSAIDs use and reduced metastasis in cancer patients: Results from a meta-analysis. Sci Rep 2017,7,1-7","journal-title":"Sci Rep"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/jgh.13478","volume":"32","author":"Facciorusso A.","year":"2017","unstructured":"Facciorusso A.; Di Maso M.; Serviddio G.; Larghi A.; Costamagna G.; Muscatiello N.; Echoendoscopic ethanol ablation of tumor combined with celiac plexus neurolysis in patients with pancreatic adenocarcinoma. J Gastroenterol Hepatol 2017,32(2),439-445","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/jso.2930240119","volume":"24","author":"Waddell W.R.","year":"1983","unstructured":"Waddell W.R.; Loughry R.W.; Sulindac for polyposis of the colon. J Surg Oncol 1983,24(1),83-87","journal-title":"J Surg Oncol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1158\/1078-0432.CCR-13-1573","volume":"20","author":"Gurpinar E.","year":"2014","unstructured":"Gurpinar E.; Grizzle W.E.; Piazza G.A.; NSAIDs inhibit tumorigenesis, but how? Clin Cancer Res 2014,20(5),1104-1113","journal-title":"Clin Cancer Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bpg.2009.11.005","volume":"24","author":"Sostres C.","year":"2010","unstructured":"Sostres C.; Gargallo C.J.; Arroyo M.T.; Lanas A.; Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol 2010,24(2),121-132","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/pharmacy4040035","volume":"4","author":"Ofori-Asenso R.","year":"2016","unstructured":"Ofori-Asenso R.; Adom A.A.; Irrational use of medicines- a summary of key concepts. Pharmacy 2016,4(4),35","journal-title":"Pharmacy"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1177\/1060028018765159","volume":"52","author":"Watanabe J.H.","year":"2018","unstructured":"Watanabe J.H.; McInnis T.; Hirsch J.D.; Cost of prescription drug\u2013related morbidity and mortality. Ann Pharmacother 2018,52(9),829-837","journal-title":"Ann Pharmacother"},{"key":"ref=26","unstructured":"World Health Organization. Medication safety in polypharmacy: Technical report. 2019. Available from:"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jtumed.2013.06.002","volume":"9","author":"Akl O.A.","year":"2014","unstructured":"Akl O.A.; El Mahalli A.A.; Elkahky A.A.; Salem A.M.; WHO\/INRUD drug use indicators at primary healthcare centers in Alexandria, Egypt. J Taibah Univ Med Sci 2014,9(1),54-64","journal-title":"J Taibah Univ Med Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.26719\/2012.18.11.1091","volume":"18","author":"El Mahalli A.A.","year":"2012","unstructured":"El Mahalli A.A.; WHO\/INRUD drug prescribing indicators at primary health care centres in Eastern province, Saudi Arabia. East Mediterr Health J 2012,18(11),1091-1096","journal-title":"East Mediterr Health J"},{"key":"ref=29","first-page":"1","author":"Qasrawi H.","year":"2020","unstructured":"Qasrawi H.; Assi S.; Ghanim N.; A descriptive study of pain relief practices among student-athletes in palestine: Focus on non-steroidal anti-inflammatory drugs, and complementary medicine and alternative medicine use. J Community Health 2020,1-9","journal-title":"J Community Health"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"567","DOI":"10.12816\/0003317","volume":"13","author":"Tayem Y.I.","year":"2013","unstructured":"Tayem Y.I.; Qubaja M.M.; Shraim R.K.; Taha O.B.; Shkheidem I.A.A.; Ibrahim M.A.; Non-steroidal anti-inflammatory drugs and antibiotics prescription trends at a central west bank hospital. Sultan Qaboos Univ Med J 2013,13(4),567-573","journal-title":"Sultan Qaboos Univ Med J"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/157488470901140212145952","volume":"9","author":"Khdour M.","year":"2014","unstructured":"Khdour M.; Hallak H.; Hejaz H.; Shaeen M.; Dweib M.; Patterns of NSAIDs use in Palestinian mid-territories: A prospective study of ambulatory patients in outpatient pharmacies. Curr Clin Pharmacol 2014,9(1),10-16","journal-title":"Curr Clin Pharmacol"},{"key":"ref=32","first-page":"14","volume":"96","author":"Ali I.Z.","year":"2019","unstructured":"Ali I.Z.; Hamzeh Al, Nisreen DR. Knowledge, attitudes and current practices of palestinian internists toward aspirin prescription title. Univ Toronto Med J 2019,96,14-16","journal-title":"Univ Toronto Med J"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.5001\/omj.2015.73","volume":"30","author":"Al-Shidhani A.","year":"2015","unstructured":"Al-Shidhani A.; Al-Rawahi N.; Al-Rawahi A.; Sathiya Murthi P.; Non-steroidal anti-inflammatory drugs (NSAIDs) use in primary health care centers in A\u2019Seeb, Muscat: A clinical audit. Oman Med J 2015,30(5),366-371","journal-title":"Oman Med J"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jsps.2020.03.001","volume":"28","author":"Al-Azayzih A.","year":"2020","unstructured":"Al-Azayzih A.; Al-Azzam S.I.; Alzoubi K.H.; Nonsteroidal anti-inflammatory drugs utilization patterns and risk of adverse events due to drug-drug interactions among elderly patients: A study from Jordan. Saudi Pharm J 2020,28(4),504-508","journal-title":"Saudi Pharm J"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.26719\/2002.8.4-5.537","volume":"8","author":"Otoom S.","year":"2002","unstructured":"Otoom S.; Batieha A.; Hadidi H.; Evaluation of drug use in Jordan using WHO prescribing indicators. EMHJ-Eastern Mediterr Health J 2002,8(4-5),537-543","journal-title":"EMHJ-Eastern Mediterr Health J"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00228-010-0872-8","volume":"66","author":"Awad A.","year":"2010","unstructured":"Awad A.; Al-Saffar N.; Evaluation of drug use practices at primary healthcare centers of Kuwait. Eur J Clin Pharmacol 2010,66(12),1247-1255","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s42506-018-0005-2","volume":"94","author":"Abd ElHafeez S.","year":"2019","unstructured":"Abd ElHafeez S.; Hegazy R.; Naga Y.; Wahdan I.; Sallam S.; Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: An epidemiological study. J Egypt Public Health Assoc 2019,94(1),8","journal-title":"J Egypt Public Health Assoc"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4314\/tjpr.v20i1.29","volume":"20","author":"Al-Taie A.","year":"2021","unstructured":"Al-Taie A.; Hussein A.N.; Albasry Z.; Prescription pattern of non-steroidal anti-inflammatory drugs (NSAIDs) among community patients with musculoskeletal and co-morbid conditions: A crosssectional study from an Iraqi province. Trop J Pharm Res 2021,20(1),203-210","journal-title":"Trop J Pharm Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4103\/jrpp.JRPP_17_45","volume":"6","author":"Taherzadeh Z.","year":"2017","unstructured":"Taherzadeh Z.; Zeinali M.; Tabeshpour J.; Prescription pattern analysis of nonsteroidal anti-inflammatory drugs in the northeastern Iranian population. J Res Pharm Pract 2017,6(4),206-210","journal-title":"J Res Pharm Pract"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/POR.S168140","volume":"10","author":"Kamel Escalante M.C.","year":"2019","unstructured":"Kamel Escalante M.C.; Abbas A.; Farah A.; Prescription patterns of analgesics, antipyretics, and non steroidal anti-inflammatory drugs for the management of fever and pain in pediatric patients: A cross-sectional, multicenter study in Latin America, Africa, and the Middle East. Pragmat Obs Res 2019,10,41-51","journal-title":"Pragmat Obs Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/jcph.188","volume":"54","author":"T\u00fcredi \u00d6.","year":"2014","unstructured":"T\u00fcredi \u00d6.; Aypak C.; Solmaz N.; Y\u0131k\u0131lkan H.; G\u00f6rpelio\u011flu S.; Concurrent prescription rate of non-steroidal anti-inflammatory drugs with antihypertensive agents. J Clin Pharmacol 2014,54(3),358-359","journal-title":"J Clin Pharmacol"},{"key":"ref=42","first-page":"1885","volume":"28","author":"Kartal M.","year":"2007","unstructured":"Kartal M.; Maral I.; Coskun O.; Prescribing pattern of general practitioners for osteoarthritis in primary care settings in Bolu, Turkey. Saudi Med J 2007,28(12),1885-1889","journal-title":"Saudi Med J"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3402\/ljm.v3i1.4744","volume":"3","author":"Sharif S.I.","year":"2008","unstructured":"Sharif S.I.; Al-Shaqra M.; Hajjar H.; Shamout A.; Wess L.; Patterns of drug prescribing in a hospital in Dubai, United Arab Emirates. Libyan J Med 2008,3(1),10-12","journal-title":"Libyan J Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.jsps.2020.07.014","volume":"28","author":"Yezli S.","year":"2020","unstructured":"Yezli S.; Zaraa S.; Yassin Y.; Mushi A.; Stergachis A.; Khan A.; Medication utilization pattern among outpatients during the Hajj mass gathering. Saudi Pharm J 2020,28(9),1122-1128","journal-title":"Saudi Pharm J"},{"key":"ref=45","first-page":"1864","volume":"25","author":"Irshaid Y.M.","year":"2004","unstructured":"Irshaid Y.M.; Al-Homrany M.A.; Hamdi A.A.; Adjepon-Yamoah K.K.; Mahfouz A.A.; A pharmacoepidemiological study of prescription pattern in outpatient clinics in Southwestern Saudi Arabia. Saudi Med J 2004,25(12),1864-1870","journal-title":"Saudi Med J"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4103\/2279-042X.141118","volume":"3","author":"Mousavi S.","year":"2014","unstructured":"Mousavi S.; Tabrizian K.; Afshari A.; Ashrafi M.H.; Dirin M.M.; Potential drug-drug interactions in prescriptions dispensed in community and hospital pharmacies in East of Iran. J Res Pharm Pract 2014,3(3),104-107","journal-title":"J Res Pharm Pract"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/pds.2106","volume":"20","author":"Ghadimi H.","year":"2011","unstructured":"Ghadimi H.; Esmaily H.M.; Wahlstrom R.; General practitioners\u2019 prescribing patterns for the elderly in a province of Iran. Pharmacoepidemiol Drug Saf 2011,20(5),482-487","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/JRS-170742","volume":"29","author":"Al Khaja K.A.J.","year":"2017","unstructured":"Al Khaja K.A.J.; Veeramuthu S.; Isa H.A.; Sequeira R.P.; Prescription audit of NSAIDs and gastroprotective strategy in elderly in primary care. Int J Risk Saf Med 2017,29(1-2),57-68","journal-title":"Int J Risk Saf Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s11096-015-0125-0","volume":"37","author":"Alhmoud E.","year":"2015","unstructured":"Alhmoud E.; Khalifa S.; Bahi A.A.; Prevalence and predictors of potentially inappropriate medications among home care elderly patients in Qatar. Int J Clin Pharm 2015,37(5),815-821","journal-title":"Int J Clin Pharm"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/jphs.12369","volume":"11","author":"Ali M.D.","year":"2020","unstructured":"Ali M.D.; Ahmad A.; A retrospective study on prescribing pattern and cost analysis of proton-pump inhibitors used among adults of Saudi Arabia. J Pharm Health Serv Res 2020,11(4),343-347","journal-title":"J Pharm Health Serv Res"},{"key":"ref=51","unstructured":"Aging and Geriatric Urology \u2013 Clinical Key. Available from:  423001294 (Accessed on: 2 March 2022)."},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5414\/CP203071","volume":"56","author":"Mazhar F.","year":"2018","unstructured":"Mazhar F.; Haider N.; Sultana J.; Akram S.; Ahmed Y.; Prospective study of NSAIDs prescribing in Saudi Arabia: Cardiovascular and gastrointestinal risk in patients with diabetes mellitus. Int J Clin Pharmacol Ther 2018,56(2),64-71","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2125.1995.tb04402.x","volume":"39","author":"Hogerzeil H.V.","year":"1995","unstructured":"Hogerzeil H.V.; Promoting rational prescribing: An international perspective. Br J Clin Pharmacol 1995,39(1),1-6","journal-title":"Br J Clin Pharmacol"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886318666230220140810","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/213820\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886318666230220140810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T12:37:48Z","timestamp":1701693468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/213820\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886318666230220140810","relation":{},"ISSN":["1574-8863"],"issn-type":[{"type":"print","value":"1574-8863"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}